BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23498789)

  • 1. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts.
    Zhou HL; Wang YT; Gao T; Wang WG; Wang YS
    Transplant Proc; 2013 Mar; 45(2):538-45. PubMed ID: 23498789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
    Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
    Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis.
    Sakai N; Wada T; Yokoyama H; Lipp M; Ueha S; Matsushima K; Kaneko S
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14098-103. PubMed ID: 16966615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Exp Clin Transplant; 2014 Aug; 12(4):314-22. PubMed ID: 25095709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA fragmentation in acute and chronic rejection after renal transplantation.
    Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
    Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of early biopsy in pediatric kidney transplantation.
    Ishimura T; Ishida T; Fujisawa M
    Aktuelle Urol; 2003 Jul; 34(4):234-8. PubMed ID: 14566671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection.
    Chareandee C; Herman WH; Hricik DE; Simonson MS
    Am J Kidney Dis; 2000 Sep; 36(3):541-9. PubMed ID: 10977786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease.
    Rossini M; Cheunsuchon B; Donnert E; Ma LJ; Thomas JW; Neilson EG; Fogo AB
    Kidney Int; 2005 Dec; 68(6):2621-8. PubMed ID: 16316338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity.
    Yilmaz S; Taskinen E; Paavonen T; Mennander A; Häyry P
    Transpl Int; 1992 May; 5(2):85-95. PubMed ID: 1627245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular infiltrates and NFκB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance.
    Becker LE; de Oliveira Biazotto F; Conrad H; Schaier M; Kihm LP; Gross-Weissmann ML; Waldherr R; Bierhaus A; Nawroth PP; Zeier M; Morath C
    Transplantation; 2012 Oct; 94(7):729-37. PubMed ID: 22955189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction.
    Miyagi M; Ishikawa Y; Mizuiri S; Aikawa A; Ohara T; Hasegawa A
    Clin Transplant; 2005 Aug; 19(4):456-65. PubMed ID: 16008588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
    Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
    Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.